|
8th Japan Human Proteome Organization Conference / 6th Annual Meeting of Japan Society for Clinical Proteomics Joint Conference
Topic: Proteomic-Scale Monoclonal Antibody Production Speaker: Dr. Wilber Huang, President and CEO of Abnova Date: 2010/07/27 Time: 9:00-10:00 am Place: Tokyo Bay Hotel Tokyu (1-7 Maihama, Urayasu-shi, Chiba, Japan)
For more information about the conference, please click here. |
+886-2-87511888
sales@abnova.com
Abnova has established a comprehensive portfolio of fully integrated solutions to address the needs of the in vitro diagnostic (IVD) industry. Abnova provides its partners and customers access to the technologies, products, and services relating to circulating rare cells, circulating exosomes, and circulating cell-free RNA for early to metastatic to recurrent disease and treatment diagnosis, prediction, guidance, and monitoring. Abnova facility is for proprietary bioreagent and high-throughput automation development and manufacturing for clinical trials and IVD commercialization. (www.abnova.com)